Andrew M. Thompson

3.2k total citations
67 papers, 2.6k citations indexed

About

Andrew M. Thompson is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Andrew M. Thompson has authored 67 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in Andrew M. Thompson's work include Cancer therapeutics and mechanisms (13 papers), Tuberculosis Research and Epidemiology (11 papers) and Synthesis and biological activity (9 papers). Andrew M. Thompson is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Tuberculosis Research and Epidemiology (11 papers) and Synthesis and biological activity (9 papers). Andrew M. Thompson collaborates with scholars based in New Zealand, United States and United Kingdom. Andrew M. Thompson's co-authors include Martin P. Harmer, William A. Denny, Helen M. Chan, Brian D. Palmer, Scott G. Franzblau, Zhenkun Ma, David W. Fry, Adrian Blaser, Baojie Wan and John W. Blunt and has published in prestigious journals such as Physical review. B, Condensed matter, Applied Physics Letters and Journal of Applied Physics.

In The Last Decade

Andrew M. Thompson

66 papers receiving 2.6k citations

Peers

Countries citing papers authored by Andrew M. Thompson

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Thompson more than expected).

Fields of papers citing papers by Andrew M. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Thompson. The network helps show where Andrew M. Thompson may publish in the future.

Co-authorship network of co-authors of Andrew M. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Thompson. A scholar is included among the top collaborators of Andrew M. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Thompson. Andrew M. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanoparticles Combining Host‐Directed Therapeutics and Antibiotics to Boost Bacterial Killing and Overall Survival of Zebrafish Embryos Infected with Mycobacterium Marinum 2024 ·Advanced Therapeutics ·(unknown), (unknown), Federico Fenaroli, Andrew M. Thompson, Anno Saris, Matthias Barz	0
2	Synthesis and Anti‐Mycobacterium tuberculosis Activity of Imidazo[2,1‐b][1,3]oxazine Derivatives against Multidrug‐Resistant Strains 2023 ·ChemMedChem ·Guilherme Fernandes, (unknown), (unknown), Débora L. Campos, Camila M. Ribeiro, (unknown), (unknown), (unknown), William A. Denny, Andrew M. Thompson, Fernando R. Pavan, Jean Leandro dos Santos	6
3	Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility 2021 ·ACS Medicinal Chemistry Letters ·Andrew M. Thompson, P. D. T. O’Connor, Vanessa Yardley, Louis Maes, Delphine Launay, Stéphanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper, William A. Denny	10
4	Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisal 2020 ·European Journal of Medicinal Chemistry ·Andrew M. Thompson, P. D. T. O’Connor, Andrew J. Marshall, Vanessa Yardley, Louis Maes, Archna Suman, Delphine Launay, Stéphanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper, William A. Denny	17
5	Chapter Four - Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis 2019 ·Andrew M. Thompson, William A. Denny	1
6	6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases 2017 ·Bioorganic & Medicinal Chemistry Letters ·Andrew M. Thompson, Adrian Blaser, Brian D. Palmer, Robert F. Anderson, S.S. Shinde, Delphine Launay, Eric Chatelain, Louis Maes, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma, William A. Denny	24
7	Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides 2017 ·Bioorganic & Medicinal Chemistry Letters ·Andrew M. Thompson, Andrew J. Marshall, Louis Maes, Nigel Yarlett, Cyrus J. Bacchi, Eric Gaukel, Stephen A. Wring, Delphine Launay, Stéphanie Braillard, Eric Chatelain, Charles E. Mowbray, William A. Denny	20
8	Biarylmethoxy 2-nitroimidazooxazine antituberculosis agents: Effects of proximal ring substitution and linker reversal on metabolism and efficacy 2015 ·Bioorganic & Medicinal Chemistry Letters ·Andrew M. Thompson, Adrian Blaser, Brian D. Palmer, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma, William A. Denny	11
9	Otago Glaucoma Surgery Outcome Study 2013 ·JAMA Ophthalmology ·Andrew M. Thompson, Anthony CB Molteno, Tui H Bevin, Peter Herbison	6
10	Synthesis and structure–activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jeff B. Smaill, Ho H. Lee, Brian D. Palmer, Andrew M. Thompson, C.J. Squire, Edward N. Baker, R J Booth, Alan J. Kraker, (unknown), William A. Denny	28
11	Moorfields Manual of Ophthalmology 2008 ·Clinical and Experimental Ophthalmology ·Andrew M. Thompson	3
12	The Levator Aponeurosis Exposed 2008 ·Ophthalmic Plastic and Reconstructive Surgery ·(unknown), Andrew M. Thompson, (unknown), Alan Pithie	3
13	Ocular toxicity of fluoroquinolones 2007 ·Clinical and Experimental Ophthalmology ·Andrew M. Thompson	79
14	Synthesis and structure–activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases 2007 ·European Journal of Medicinal Chemistry ·Jeff B. Smaill, Edward N. Baker, R J Booth, Alexander J. Bridges, James M. Dickson, Ellen M. Dobrusin, Ivan Ivanović, Alan J. Kraker, Ho H. Lee, Elizabeth A. Lunney, Daniel F. Ortwine, Brian D. Palmer, John Quin, C.J. Squire, Andrew M. Thompson, William A. Denny	28
15	The Auckland Cataract Study: 2 year postoperative assessment of aspects of clinical, visual, corneal topographic and satisfaction outcomes 2004 ·British Journal of Ophthalmology ·Andrew M. Thompson	38
16	Synthesis of 7-substituted 3-aryl-1,6-naphthyridin-2-amines and 7-substituted 3-aryl-1,6-naphthyridin-2(1H )-ones via diazotization of 3-aryl-1,6-naphthyridine-2,7-diamines 2000 ·Journal of the Chemical Society Perkin Transactions 1 ·Andrew M. Thompson, H. D. Hollis Showalter, William A. Denny	6
17	Flux-line lattices in artificially layered superconductors 1998 ·Physical review. B, Condensed matter ·Andrew M. Thompson, M. A. Moore	3
18	Tyrosine Kinase Inhibitors. 4. Structure-Activity Relationships among N- and 3-Substituted 2,2'-Dithiobis(1H-indoles) for in vitro Inhibition of Receptor and Nonreceptor Protein Tyrosine Kinases 1995 ·Journal of Medicinal Chemistry ·Brian D. Palmer, Gordon W. Rewcastle, Andrew M. Thompson, Maruta Boyd, H. D. Hollis Showalter, Anthony D. Sercel, David W. Fry, Alan J. Kraker, William A. Denny	61
19	Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases 1994 ·Journal of Medicinal Chemistry ·Andrew M. Thompson, David W. Fry, A J Kraker, William A. Denny	23
20	Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids) 1993 ·Journal of Medicinal Chemistry ·Andrew M. Thompson, Gordon W. Rewcastle, Moana Tercel, Ellen M. Dobrusin, David W. Fry, Alan J. Kraker, William A. Denny	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact